NCT00144391View on ClinicalTrials.gov

Testosterone Gel Applied to Women With Pituitary Gland Problems

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Panhypopituitarism
Interventions
DRUG

Transdermal Testosterone gel

2.0 mg per pump of transdermal testosterone gel. Study patients receive either 2 pumps of transdermal testosterone gel per thigh per day or they receive 2 pumps per placebo gel per thigh per day for 6 months.

Trial Locations (1)

90059

Charles Drew University of Medicine and Science, Los Angeles

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Charles Drew University of Medicine and Science

OTHER

NCT00144391 - Testosterone Gel Applied to Women With Pituitary Gland Problems | Biotech Hunter | Biotech Hunter